Exposure to estrogenic compounds has been shown to epigenetically reprogram the female reproductive tract and may contribute to ovarian cancer. The goal of this study was to compare the effect of estradiol or bisphenol A (BPA) on the expression of histone-modifying enzymes (HMEs) in ovarian cancer cells. Using 2 human ovarian cancer cell lines, we examined the expression of SET8, a histone methyltransferase, and SIRT1, a histone deacetylase, after exposure to estrogen or BPA. These experiments were carried out in complete media (fetal bovine serum) that contain natural hormones to understand the impact of additional exposure to estrogen or BPA on HME expression. We found differential expression of the HMEs in the different models examined and between the different compounds. Further, we determined that the changes in gene expression occurred via estrogen receptor signaling using the estrogen receptor antagonist, ICI 182,780 (fulvestrant).

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831029PMC
http://dx.doi.org/10.1177/1559325816640682DOI Listing

Publication Analysis

Top Keywords

ovarian cancer
16
estradiol bisphenol
8
cancer cells
8
exposure estrogen
8
estrogen bpa
8
estrogen receptor
8
expression
6
differential effects
4
effects estradiol
4
bisphenol set8
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!